Final Programme - World Heart Federation

Wednesday, 21 May 2008
mekong - oChRe Pavillion - 16:00-17:30
Clinical Seminar
hyPeRglyCemia, inflammation and CoRonaRy aRteRy disease:
neW RelationshiPs?
Chairs: Jose Sala (ARGENTINA), Corbalan Ramon (CHILE)
16:00 Hyperglycemia as a risk factor in AMI: New insights
Jose Nicolau (BRAZIL)
16:30 Do biomarkers change pharmacological interventions in Stable Coronary Artery Disease?
Cagide Arturo (ARGENTINA)
17:00 The role of lipids in chronic coronary disease
Ada Cuevas (CHILE)
mississiPPi - yelloW Pavillion - 16:00-17:30
Symposium
PRevention of CaRdiovasCulaR disease in asymPtomatiC Patients
Chairs: Carlos Nijensohn (ARGENTINA), Alejandro Gómez Monroy (ARGENTINA)
16:00 The impact of policies to reduce salt consumption on cardiovascular health
Hassell Trevor (BARBADOS)
16:30 Experience in developing national policy frameworks for prevention and control of CVD
Herman Schargrodsky (ARGENTINA)
17:00 Cost effectiveness of cardiovascular prevention programmes
Shah Ebrahim (UNITED KINGDOM)
ganges - gReen Pavillion - 16:00-17:30
Clinical Seminar
ComPlex Patients and ComPlex deCisions - PaRt tWo
Chairs:C. Vozzi (ARGENTINA), Miguel Ballarino(ARGENTINA)
16:00 When do gender differences exist in patients undergoing planned PCI?
Spencer King III (UNITED STATES)
16:22 When does a bifurcation lesion require more than one stent?
Costantino Costantini (BRAZIL)
16:44 An old concept a new approach. Autoretroperfusion of the coronary sinus in no-option patients
Jose Navia (ARGENTINA)
17:06 PCI in the diabetic patient: Outcomes for focal and diffuse disease
Alexander Abizaid (BRAZIL)